CNC250117P64000
- 1.45
- 0.000.00%
Centene Newsroom
Bernstein Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $80
Bernstein Reaffirms Their Buy Rating on Centene (CNC)
Baird Maintains Centene(CNC.US) With Hold Rating, Raises Target Price to $71
Baird Adjusts Centene Price Target to $71 From $66, Maintains Neutral Rating
Jefferies Maintains Centene(CNC.US) With Sell Rating, Maintains Target Price $52
Cautious Outlook on Centene: Sell Rating Due to Market Challenges and Margin Pressures
Centene Price Target Cut to $75.00/Share From $80.00 by JP Morgan
Centene Coverage Assumed by JP Morgan at Overweight Vs Previous Rating of Neutral
Centene Analyst Ratings
J.P. Morgan Initiates Centene(CNC.US) With Buy Rating, Announces Target Price $75
Analysts Conflicted on These Healthcare Names: Talkspace (TALK), Centene (CNC) and Alkermes (ALKS)
Analysts Offer Insights on Healthcare Companies: Repare Therapeutics (RPTX) and Centene (CNC)
Centene Is Maintained at Buy by Truist Securities
Barclays Maintains Overweight on Centene, Raises Price Target to $93
Centene Is Maintained at Outperform by Oppenheimer
Wells Fargo Maintains Centene(CNC.US) With Buy Rating, Raises Target Price to $76
Oppenheimer Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $85
A Quick Look at Today's Ratings for Centene(CNC.US), With a Forecast Between $73 to $93
Oppenheimer Reaffirms Their Buy Rating on Centene (CNC)
Analysts Are Bullish on These Healthcare Stocks: Medios AG (MEDOF), Centene (CNC)